SEC Form 4 · accession 0001127602-18-008322
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Gunnar Knell
Officer — CSVP&Chief Accounting Officer
Period of report
Feb 23, 2018
Accepted (ET)
Feb 26, 2018 · 1:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 23, 2018 | A | 758 | $0.00 | A | 1,588 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F2 | $109.34 | Feb 23, 2018 | A | 3,419 | A | Feb 23, 2019 | Feb 23, 2023 | Common Stock | 3,419 | 3,419 | D |
Explanation of responses
- F1Consists of 758 unvested restricted stock units that vest as follows: 189 shares vest one (1) year from the date of issuance, 190 shares vest two (2) years from the date of issuance, 189 shares vest three (3) years from the date of issuance and 190 shares vest four (4) years from the date of issuance.
- F2Stock options vest as follows: 854 options vest one (1) year from the date of grant, 855 options vest two (2) years from the date of grant, 855 options vest three (3) years from the date of grant, and 855 options vest four (4) years from the date of grant.